ll 37 Search Results


ll37 solution  (MedChemExpress)
94
MedChemExpress ll37 solution
Ll37 Solution, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ll37 solution/product/MedChemExpress
Average 94 stars, based on 1 article reviews
ll37 solution - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
elisa kits  (Hycult Biotech)
95
Hycult Biotech elisa kits
Elisa Kits, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kits/product/Hycult Biotech
Average 95 stars, based on 1 article reviews
elisa kits - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
anti ll37 antibody  (Novus Biologicals)
93
Novus Biologicals anti ll37 antibody
Anti Ll37 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ll37 antibody/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
anti ll37 antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
elisa kit  (Elabscience Biotechnology)
94
Elabscience Biotechnology elisa kit
Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kit/product/Elabscience Biotechnology
Average 94 stars, based on 1 article reviews
elisa kit - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
ll 37  (Tocris)
94
Tocris ll 37
Lactate‐mediated acidification dampens the bactericidal activity <t>of</t> <t>LL‐37</t> against P. aeruginosa . (A) Lactate concentrations of the sputa were collected from bronchiectasis (BE) patients and their relatives as controls in cohort 3. Induced sputa were collected when needed. The comparison was performed with an unpaired Student t ‐test. (B) Comparison of the sputum LL‐37 concentrations between BE patients with different microbiology test results in cohort 3. A comparison was performed with one‐way analysis of variance (ANOVA) with Welch's test. (C) The lactate concentrations in bronchoalveolar lavage fluid (BALF) from mice with or without P. aeruginosa chronic lung infection. A comparison was performed with an unpaired Student t ‐test. (D) The survivals of three clinical P. aeruginosa isolated from BE patients after the treatment with LL‐37 in vitro. Comparison between the untreated and LL‐37‐treated groups (120 µg/mL) was performed with an unpaired Student t ‐test. (E) Percentages of survived clinical P. aeruginosa isolate SHPHC2 post‐LL‐37 treatment in the conditions with various pH adjusted by lactate. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups, p ‐values were indicated in the figure, and results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.
Ll 37, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ll 37/product/Tocris
Average 94 stars, based on 1 article reviews
ll 37 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
fluorescein conjugated cathelicidin antimicrobial peptide ll 37  (Rockland Immunochemicals)
94
Rockland Immunochemicals fluorescein conjugated cathelicidin antimicrobial peptide ll 37
Lactate‐mediated acidification dampens the bactericidal activity <t>of</t> <t>LL‐37</t> against P. aeruginosa . (A) Lactate concentrations of the sputa were collected from bronchiectasis (BE) patients and their relatives as controls in cohort 3. Induced sputa were collected when needed. The comparison was performed with an unpaired Student t ‐test. (B) Comparison of the sputum LL‐37 concentrations between BE patients with different microbiology test results in cohort 3. A comparison was performed with one‐way analysis of variance (ANOVA) with Welch's test. (C) The lactate concentrations in bronchoalveolar lavage fluid (BALF) from mice with or without P. aeruginosa chronic lung infection. A comparison was performed with an unpaired Student t ‐test. (D) The survivals of three clinical P. aeruginosa isolated from BE patients after the treatment with LL‐37 in vitro. Comparison between the untreated and LL‐37‐treated groups (120 µg/mL) was performed with an unpaired Student t ‐test. (E) Percentages of survived clinical P. aeruginosa isolate SHPHC2 post‐LL‐37 treatment in the conditions with various pH adjusted by lactate. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups, p ‐values were indicated in the figure, and results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.
Fluorescein Conjugated Cathelicidin Antimicrobial Peptide Ll 37, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescein conjugated cathelicidin antimicrobial peptide ll 37/product/Rockland Immunochemicals
Average 94 stars, based on 1 article reviews
fluorescein conjugated cathelicidin antimicrobial peptide ll 37 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
anti ll37 antibody  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology anti ll37 antibody
Lactate‐mediated acidification dampens the bactericidal activity <t>of</t> <t>LL‐37</t> against P. aeruginosa . (A) Lactate concentrations of the sputa were collected from bronchiectasis (BE) patients and their relatives as controls in cohort 3. Induced sputa were collected when needed. The comparison was performed with an unpaired Student t ‐test. (B) Comparison of the sputum LL‐37 concentrations between BE patients with different microbiology test results in cohort 3. A comparison was performed with one‐way analysis of variance (ANOVA) with Welch's test. (C) The lactate concentrations in bronchoalveolar lavage fluid (BALF) from mice with or without P. aeruginosa chronic lung infection. A comparison was performed with an unpaired Student t ‐test. (D) The survivals of three clinical P. aeruginosa isolated from BE patients after the treatment with LL‐37 in vitro. Comparison between the untreated and LL‐37‐treated groups (120 µg/mL) was performed with an unpaired Student t ‐test. (E) Percentages of survived clinical P. aeruginosa isolate SHPHC2 post‐LL‐37 treatment in the conditions with various pH adjusted by lactate. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups, p ‐values were indicated in the figure, and results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.
Anti Ll37 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ll37 antibody/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
anti ll37 antibody - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
human ll 37 elisa kit  (Novus Biologicals)
92
Novus Biologicals human ll 37 elisa kit
Lactate‐mediated acidification dampens the bactericidal activity <t>of</t> <t>LL‐37</t> against P. aeruginosa . (A) Lactate concentrations of the sputa were collected from bronchiectasis (BE) patients and their relatives as controls in cohort 3. Induced sputa were collected when needed. The comparison was performed with an unpaired Student t ‐test. (B) Comparison of the sputum LL‐37 concentrations between BE patients with different microbiology test results in cohort 3. A comparison was performed with one‐way analysis of variance (ANOVA) with Welch's test. (C) The lactate concentrations in bronchoalveolar lavage fluid (BALF) from mice with or without P. aeruginosa chronic lung infection. A comparison was performed with an unpaired Student t ‐test. (D) The survivals of three clinical P. aeruginosa isolated from BE patients after the treatment with LL‐37 in vitro. Comparison between the untreated and LL‐37‐treated groups (120 µg/mL) was performed with an unpaired Student t ‐test. (E) Percentages of survived clinical P. aeruginosa isolate SHPHC2 post‐LL‐37 treatment in the conditions with various pH adjusted by lactate. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups, p ‐values were indicated in the figure, and results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.
Human Ll 37 Elisa Kit, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ll 37 elisa kit/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
human ll 37 elisa kit - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
pbs  (Rockland Immunochemicals)
94
Rockland Immunochemicals pbs
Lactate‐mediated acidification dampens the bactericidal activity <t>of</t> <t>LL‐37</t> against P. aeruginosa . (A) Lactate concentrations of the sputa were collected from bronchiectasis (BE) patients and their relatives as controls in cohort 3. Induced sputa were collected when needed. The comparison was performed with an unpaired Student t ‐test. (B) Comparison of the sputum LL‐37 concentrations between BE patients with different microbiology test results in cohort 3. A comparison was performed with one‐way analysis of variance (ANOVA) with Welch's test. (C) The lactate concentrations in bronchoalveolar lavage fluid (BALF) from mice with or without P. aeruginosa chronic lung infection. A comparison was performed with an unpaired Student t ‐test. (D) The survivals of three clinical P. aeruginosa isolated from BE patients after the treatment with LL‐37 in vitro. Comparison between the untreated and LL‐37‐treated groups (120 µg/mL) was performed with an unpaired Student t ‐test. (E) Percentages of survived clinical P. aeruginosa isolate SHPHC2 post‐LL‐37 treatment in the conditions with various pH adjusted by lactate. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups, p ‐values were indicated in the figure, and results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.
Pbs, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbs/product/Rockland Immunochemicals
Average 94 stars, based on 1 article reviews
pbs - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
scramble ll 37  (TargetMol)
94
TargetMol scramble ll 37
Lactate‐mediated acidification dampens the bactericidal activity <t>of</t> <t>LL‐37</t> against P. aeruginosa . (A) Lactate concentrations of the sputa were collected from bronchiectasis (BE) patients and their relatives as controls in cohort 3. Induced sputa were collected when needed. The comparison was performed with an unpaired Student t ‐test. (B) Comparison of the sputum LL‐37 concentrations between BE patients with different microbiology test results in cohort 3. A comparison was performed with one‐way analysis of variance (ANOVA) with Welch's test. (C) The lactate concentrations in bronchoalveolar lavage fluid (BALF) from mice with or without P. aeruginosa chronic lung infection. A comparison was performed with an unpaired Student t ‐test. (D) The survivals of three clinical P. aeruginosa isolated from BE patients after the treatment with LL‐37 in vitro. Comparison between the untreated and LL‐37‐treated groups (120 µg/mL) was performed with an unpaired Student t ‐test. (E) Percentages of survived clinical P. aeruginosa isolate SHPHC2 post‐LL‐37 treatment in the conditions with various pH adjusted by lactate. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups, p ‐values were indicated in the figure, and results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.
Scramble Ll 37, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scramble ll 37/product/TargetMol
Average 94 stars, based on 1 article reviews
scramble ll 37 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
murine igg anti ll 37 antibodies  (Novus Biologicals)
90
Novus Biologicals murine igg anti ll 37 antibodies
Lactate‐mediated acidification dampens the bactericidal activity <t>of</t> <t>LL‐37</t> against P. aeruginosa . (A) Lactate concentrations of the sputa were collected from bronchiectasis (BE) patients and their relatives as controls in cohort 3. Induced sputa were collected when needed. The comparison was performed with an unpaired Student t ‐test. (B) Comparison of the sputum LL‐37 concentrations between BE patients with different microbiology test results in cohort 3. A comparison was performed with one‐way analysis of variance (ANOVA) with Welch's test. (C) The lactate concentrations in bronchoalveolar lavage fluid (BALF) from mice with or without P. aeruginosa chronic lung infection. A comparison was performed with an unpaired Student t ‐test. (D) The survivals of three clinical P. aeruginosa isolated from BE patients after the treatment with LL‐37 in vitro. Comparison between the untreated and LL‐37‐treated groups (120 µg/mL) was performed with an unpaired Student t ‐test. (E) Percentages of survived clinical P. aeruginosa isolate SHPHC2 post‐LL‐37 treatment in the conditions with various pH adjusted by lactate. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups, p ‐values were indicated in the figure, and results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.
Murine Igg Anti Ll 37 Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/murine igg anti ll 37 antibodies/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
murine igg anti ll 37 antibodies - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
monoclonal antibody against ll 37  (Novus Biologicals)
90
Novus Biologicals monoclonal antibody against ll 37
Lactate‐mediated acidification dampens the bactericidal activity <t>of</t> <t>LL‐37</t> against P. aeruginosa . (A) Lactate concentrations of the sputa were collected from bronchiectasis (BE) patients and their relatives as controls in cohort 3. Induced sputa were collected when needed. The comparison was performed with an unpaired Student t ‐test. (B) Comparison of the sputum LL‐37 concentrations between BE patients with different microbiology test results in cohort 3. A comparison was performed with one‐way analysis of variance (ANOVA) with Welch's test. (C) The lactate concentrations in bronchoalveolar lavage fluid (BALF) from mice with or without P. aeruginosa chronic lung infection. A comparison was performed with an unpaired Student t ‐test. (D) The survivals of three clinical P. aeruginosa isolated from BE patients after the treatment with LL‐37 in vitro. Comparison between the untreated and LL‐37‐treated groups (120 µg/mL) was performed with an unpaired Student t ‐test. (E) Percentages of survived clinical P. aeruginosa isolate SHPHC2 post‐LL‐37 treatment in the conditions with various pH adjusted by lactate. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups, p ‐values were indicated in the figure, and results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.
Monoclonal Antibody Against Ll 37, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal antibody against ll 37/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
monoclonal antibody against ll 37 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Lactate‐mediated acidification dampens the bactericidal activity of LL‐37 against P. aeruginosa . (A) Lactate concentrations of the sputa were collected from bronchiectasis (BE) patients and their relatives as controls in cohort 3. Induced sputa were collected when needed. The comparison was performed with an unpaired Student t ‐test. (B) Comparison of the sputum LL‐37 concentrations between BE patients with different microbiology test results in cohort 3. A comparison was performed with one‐way analysis of variance (ANOVA) with Welch's test. (C) The lactate concentrations in bronchoalveolar lavage fluid (BALF) from mice with or without P. aeruginosa chronic lung infection. A comparison was performed with an unpaired Student t ‐test. (D) The survivals of three clinical P. aeruginosa isolated from BE patients after the treatment with LL‐37 in vitro. Comparison between the untreated and LL‐37‐treated groups (120 µg/mL) was performed with an unpaired Student t ‐test. (E) Percentages of survived clinical P. aeruginosa isolate SHPHC2 post‐LL‐37 treatment in the conditions with various pH adjusted by lactate. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups, p ‐values were indicated in the figure, and results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.

Journal: MedComm

Article Title: Outer membrane vesicle contributes to the Pseudomonas aeruginosa resistance to antimicrobial peptides in the acidic airway of bronchiectasis patients

doi: 10.1002/mco2.70084

Figure Lengend Snippet: Lactate‐mediated acidification dampens the bactericidal activity of LL‐37 against P. aeruginosa . (A) Lactate concentrations of the sputa were collected from bronchiectasis (BE) patients and their relatives as controls in cohort 3. Induced sputa were collected when needed. The comparison was performed with an unpaired Student t ‐test. (B) Comparison of the sputum LL‐37 concentrations between BE patients with different microbiology test results in cohort 3. A comparison was performed with one‐way analysis of variance (ANOVA) with Welch's test. (C) The lactate concentrations in bronchoalveolar lavage fluid (BALF) from mice with or without P. aeruginosa chronic lung infection. A comparison was performed with an unpaired Student t ‐test. (D) The survivals of three clinical P. aeruginosa isolated from BE patients after the treatment with LL‐37 in vitro. Comparison between the untreated and LL‐37‐treated groups (120 µg/mL) was performed with an unpaired Student t ‐test. (E) Percentages of survived clinical P. aeruginosa isolate SHPHC2 post‐LL‐37 treatment in the conditions with various pH adjusted by lactate. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups, p ‐values were indicated in the figure, and results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.

Article Snippet: The final concentrations of LL‐37 (Tocris Bioscience, cat. 5213), P. aeruginosa ‐derived OMVs, HHQ (TargetMol, cat. T19713), PQS (TargetMol, cat. T38373) and Cl‐adimine (MedChemExpress, cat. HY‐100574) were stated in the main text.

Techniques: Activity Assay, Comparison, Infection, Isolation, In Vitro

P. aeruginosa produces outer membrane vesicles (OMVs) to resist LL‐37‐mediated killing. (A) Quantification of OMVs produced by P. aeruginosa in the lactate‐mediated acidic environment by measuring FM 4‐64 fluorescence. One‐way analysis of variance (ANOVA) with Welch's test was used for statistical analysis. (B) Nanoparticle tracking analysis and transmission electron microscopy of OMVs isolated from P. aeruginosa overnight culture by ultracentrifugation. (C) Survival of P. aeruginosa PAO1 post‐LL‐37 treatment with the additions of OMVs of different dosages. The OMVs added were quantified by measuring the total proteins enwrapped. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups and the p ‐value was shown. (D) The role of OMVs in the acidic condition‐induced strengthening of P. aeruginosa LL‐37 resistance was determined by adding Cl‐adimine to the bacteria‐killing system. The final concentration of Cl‐diamine was indicated on the diagram. The differences between groups were statistically analyzed by using one‐way ANOVA with Welch's test, with the p values of multiple comparisons indicated in the figures. Results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.

Journal: MedComm

Article Title: Outer membrane vesicle contributes to the Pseudomonas aeruginosa resistance to antimicrobial peptides in the acidic airway of bronchiectasis patients

doi: 10.1002/mco2.70084

Figure Lengend Snippet: P. aeruginosa produces outer membrane vesicles (OMVs) to resist LL‐37‐mediated killing. (A) Quantification of OMVs produced by P. aeruginosa in the lactate‐mediated acidic environment by measuring FM 4‐64 fluorescence. One‐way analysis of variance (ANOVA) with Welch's test was used for statistical analysis. (B) Nanoparticle tracking analysis and transmission electron microscopy of OMVs isolated from P. aeruginosa overnight culture by ultracentrifugation. (C) Survival of P. aeruginosa PAO1 post‐LL‐37 treatment with the additions of OMVs of different dosages. The OMVs added were quantified by measuring the total proteins enwrapped. One‐way ANOVA with Welch's test was used for statistical analysis in both LL37‐treated and untreated groups and the p ‐value was shown. (D) The role of OMVs in the acidic condition‐induced strengthening of P. aeruginosa LL‐37 resistance was determined by adding Cl‐adimine to the bacteria‐killing system. The final concentration of Cl‐diamine was indicated on the diagram. The differences between groups were statistically analyzed by using one‐way ANOVA with Welch's test, with the p values of multiple comparisons indicated in the figures. Results with a p ‐value less than 0.05 were considered statistically significant. The error bars plotted indicate the standard error of the mean.

Article Snippet: The final concentrations of LL‐37 (Tocris Bioscience, cat. 5213), P. aeruginosa ‐derived OMVs, HHQ (TargetMol, cat. T19713), PQS (TargetMol, cat. T38373) and Cl‐adimine (MedChemExpress, cat. HY‐100574) were stated in the main text.

Techniques: Membrane, Produced, Fluorescence, Transmission Assay, Electron Microscopy, Isolation, Bacteria, Concentration Assay